Loading…
Solid-phase extraction in clinical biochemistry
In order to measure low concentrations of analytes in plasma and urine, it is often necessary to extract and concentrate them. With solid-phase extraction (SPE), this is achieved by partitioning the analytes between a solid and a liquid or headspace vapour. A wide range of high-quality materials is...
Saved in:
Published in: | Annals of Clinical Biochemistry 2002-09, Vol.39 (5), p.464-477 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In order to measure low concentrations of analytes in plasma and urine, it is often
necessary to extract and concentrate them. With solid-phase extraction (SPE), this is
achieved by partitioning the analytes between a solid and a liquid or headspace
vapour. A wide range of high-quality materials is now available to do this, offering
a variety of separation modes for different applications. These include partitioning
using reversed-phase, normal-phase, ion-exchange, restricted-access and
immunoaffinity sorbents or molecularly imprinted polymers and, increasingly,
combinations of these processes. Solid-phase microextraction was introduced to
analyse volatile and semi-volatile compounds. The range of sampling formats has
expanded from simple packed syringes to cartridges, disks, SPE pipette tips and
96-well plates. These developments have facilitated automated off- and on-line sample
processing. The basic principles of SPE and the recent innovations are reviewed here.
This is a technological growth area. Some of the developments are finding application
in clinical toxicology. However, they could also be of wider value in clinical
chemistry - for example, for analyses of volatile and non-volatile metabolites,
peptides, radioactive elements and trace metal speciation. |
---|---|
ISSN: | 0004-5632 1758-1001 |
DOI: | 10.1258/000456302320314476 |